Literature DB >> 31375553

MicroRNA-21 promotes progression of breast cancer via inhibition of mitogen-activated protein kinase10 (MAPK10).

Yilin Xie1, Yaqing Liu1, Xiaoyue Fan1, Lan Zhang1, Qing Li2, Shenglei Li3, Honglei Wang1, Yi Xiao1.   

Abstract

OBJECTIVE: The present study aims to investigate microRNAs (miRNAs) and messenger RNAs (mRNAs) associated with breast cancer, and to have a better understanding of the mechanism of miRNAs in breast cancer using bioinformatics tools.
METHODS: Microarray analysis was performed to predict differentially expressed miRNAs related to breast cancer, followed by prediction and verification of target genes. Human breast cancer cells were transfected and divided into Blank group, NC group, miR-21-5p mimic group, miR-21-5p inhibitor group and siRNA-MAPK10 group. RT-qPCR and Western blot analysis were used to detect mRNA and protein expressions of MAPK10 in tissues and transfected cells, MTT assay, scratch test and Transwell assay for detection of the proliferation, migration and invasion, and Annexin-V-R-PE assay for apoptosis of different cell lines.
RESULTS: Highly expressed miR-21-5p and lowly expressed MAPK10 were selected for subsequent experiments, according to the microarray analysis. RT-qPCR showed that the expression of MAPK10 in breast cancer tissues was significantly lower than that in adjacent tissues, while it was reciprocal in expression of miR-21. miR-21-5p negatively regulated MAPK10. The expression of MAPK10 reduced in response to miR-21-5p mimic treatment. Compared with the Blank and NC groups, the proliferation, migration, invasion and metastasis of breast cancer cells decreased, and the apoptosis of breast cancer cells increased in the miR-21-5p inhibitor group and siRNA-MAPK10 group, while it was reciprocal in the miR-21-5p mimic group.
CONCLUSION: MiR-21 promotes the proliferation, migration and invasion and inhibits the apoptosis of breast cancer cells by inhibiting MAPK10. ©2019 The Author(s).

Entities:  

Keywords:  Apoptosis; Invasion; MicroRNA-21; Migration; Mitogen-activated protein kinase10; Proliferation

Year:  2019        PMID: 31375553     DOI: 10.1042/BSR20181000

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  6 in total

1.  A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks.

Authors:  Chongze Yuan; Haojie Chen; Shiqi Tu; Hsin-Yi Huang; Yunjian Pan; Xiuqi Gui; Muyu Kuang; Xuxia Shen; Qiang Zheng; Yang Zhang; Chao Cheng; Hui Hong; Xiaoting Tao; Yizhou Peng; Xingxin Yao; Feilong Meng; Hongbin Ji; Zhen Shao; Yihua Sun
Journal:  Genome Biol       Date:  2021-05-17       Impact factor: 13.583

2.  Long non-coding RNA CASC7 suppresses malignant behaviors of breast cancer by regulating miR-21-5p/FASLG axis.

Authors:  Genjin Wang; Peng Duan; Feng Liu; Zhengkuo Wei
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

3.  Establishment of a Novel Prognostic Prediction Model for Gastric Cancer Based on Necroptosis-Related Genes.

Authors:  Zhong-Zhong Zhu; Guanglin Zhang; Jianping Liu
Journal:  Pathol Oncol Res       Date:  2022-09-15       Impact factor: 2.874

4.  Propofol suppresses the progression of non‑small cell lung cancer via downregulation of the miR‑21‑5p/MAPK10 axis.

Authors:  Xinhua Wu; Xuebin Li; Guiping Xu
Journal:  Oncol Rep       Date:  2020-05-21       Impact factor: 3.906

5.  microRNA-21-5p from M2 macrophage-derived extracellular vesicles promotes the differentiation and activity of pancreatic cancer stem cells by mediating KLF3.

Authors:  Jian Chang; Hanjun Li; Zhongchao Zhu; Pei Mei; Weimin Hu; Xingcheng Xiong; Jing Tao
Journal:  Cell Biol Toxicol       Date:  2021-03-17       Impact factor: 6.819

6.  Integrated miRNA-mRNA network revealing the key molecular characteristics of ossification of the posterior longitudinal ligament.

Authors:  Guoyong Xu; Chong Liu; Tuo Liang; Zhaojie Qin; Chao Jie Yu; Zide Zhang; Jie Jiang; Jiarui Chen; Xinli Zhan
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.